Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LCTX Lineage Cell Therapeutics Inc

交易中 11-22 10:09:00 EST

0.5980

-0.0020

-0.33%

最高0.6196	最低0.5826	成交量121.50万
今开0.6196	昨收0.6000	日振幅6.17%
总市值1.13亿	流通市值8,751万	总股本1.89亿
成交额72.62万	换手率0.83%	流通股本1.46亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LCTX","market":"US","secType":"STK","nameCN":"Lineage Cell Therapeutics Inc","latestPrice":0.598,"timestamp":1732288121111,"preClose":0.6,"halted":0,"volume":1215024,"delay":0,"floatShares":146337824,"shares":188837375,"eps":-0.109359,"marketStatus":"交易中","marketStatusCode":2,"change":-0.002,"latestTime":"11-22 10:09:00 EST","open":0.6196,"high":0.6196,"low":0.5826,"amount":726175.9824336,"amplitude":0.061667,"askPrice":0.6,"askSize":100,"bidPrice":0.59,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-0.109359,"exchange":"AMEX","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":699771600000,"adjPreClose":0.6,"preHourTrading":{"tag":"盘前","latestPrice":0.6299,"preClose":0.6,"latestTime":"09:29 EST","volume":30355,"amount":19154.7626608,"timestamp":1732285762614},"postHourTrading":{"tag":"盘后","latestPrice":0.605,"preClose":0.6,"latestTime":"19:47 EST","volume":13164,"amount":7925.6995,"timestamp":1732236439662},"volumeRatio":3.885777,"impliedVol":0.8848,"impliedVolPercentile":0.4802},"requestUrl":"/m/hq/s/LCTX/tweets","defaultTab":"tweets","newsList":[{"id":"2485497420","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速跳水5.66%报0.605美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497420?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:39","pubTimestamp":1732199958,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时39分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.66%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122391898e43edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122391898e43edd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LINE","BK4224","LCTX"],"gpt_icon":0},{"id":"2484110850","title":"Lineage Cell Therapeutics, Inc.股价重挫19.73% 市值跌2701.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484110850?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:31","pubTimestamp":1732113078,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时31分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速下挫19.73%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为439.66%、130.77%、88.84%，振幅较大的相关个股有Silexion Therapeutics Corp、Tonix Pharmaceuticals Holding Corp.、Forte Biosciences, Inc.，振幅分别为17.77%、17.64%、17.55%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311895be4c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311895be4c8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4224","LINE","BK4139","LCTX"],"gpt_icon":0},{"id":"2484764466","title":"Lineage Cell Therapeutics, Inc.盘中异动 急速上涨5.41%报0.911美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484764466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484764466?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:36","pubTimestamp":1731940563,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时36分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.41%。截至发稿，该股报0.911美元/股，成交量3.6726万股，换手率0.02%，振幅2.05%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360395be48b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360395be48b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LCTX","BK4224","BK4139","LENZ"],"gpt_icon":0},{"id":"2483377366","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅拉升5.08%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483377366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483377366?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:30","pubTimestamp":1731681013,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时30分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速上涨5.08%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Lyra Therapeutics, Inc.、Cybin Inc.、Senti Biosciences, Inc.涨幅较大，Tc Biopharm  Plc、Elevai Labs, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2672.48%、153.67%、44.16%，振幅较大的相关个股有Abvc Biopharma, Inc.、Gain Therapeutics, Inc.、Bioatla, Inc.，振幅分别为4.17%、4.01%、2.34%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522301498e42ea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522301498e42ea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224","LCTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2483983992","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近午盘大幅跳水6.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483983992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483983992?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:39","pubTimestamp":1731515977,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时39分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速下挫6.89%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Syros Pharmaceuticals, Inc.较为活跃，换手率分别为484.15%、288.62%、105.25%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Calidi Biotherapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为88.00%、67.77%、52.89%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114003937971a6574&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114003937971a6574&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LINE","BK4224","BK4139","LENZ"],"gpt_icon":0},{"id":"2481998143","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速拉升5.03%报0.887美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481998143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481998143?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:09","pubTimestamp":1730905745,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时09分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.03%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1604.05%、179.21%、81.08%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Protagenic Therapeutics, Inc.、Neuraxis, Inc.，振幅分别为73.16%、24.63%、23.51%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110623090598e40eb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110623090598e40eb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LENZ","BK4139","LINE","LCTX"],"gpt_icon":0},{"id":"2478867134","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478867134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478867134?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:39","pubTimestamp":1730122777,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时39分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.33%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213938a1f25131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213938a1f25131&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","BK4224","LINE","LENZ"],"gpt_icon":0},{"id":"2477897913","title":"Lineage Cell Therapeutics, Inc.盘中异动 急速下挫5.21%报0.860美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477897913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477897913?lang=zh_cn&edition=full","pubTime":"2024-10-22 02:39","pubTimestamp":1729535956,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日02时39分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速下跌5.21%。截至发稿，该股报0.860美元/股，成交量25.2819万股，换手率0.13%，振幅7.21%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022023916971a16dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022023916971a16dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4224","LINE","BK4139","LCTX"],"gpt_icon":0},{"id":"2476978679","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476978679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476978679?lang=zh_cn&edition=full","pubTime":"2024-10-17 03:51","pubTimestamp":1729108260,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日03时51分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速上涨5.23%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017035100a1e12932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017035100a1e12932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LENZ","BK4224","LCTX","BK4139"],"gpt_icon":0},{"id":"2474729930","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌10.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474729930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474729930?lang=zh_cn&edition=full","pubTime":"2024-10-11 00:14","pubTimestamp":1728576881,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日00时14分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速下挫10.21%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101100144298e3bc2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101100144298e3bc2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LINE","LENZ","BK4224","LCTX"],"gpt_icon":0},{"id":"2472574735","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472574735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472574735?lang=zh_cn&edition=full","pubTime":"2024-10-03 01:09","pubTimestamp":1727888989,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日01时09分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅拉升5.00%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100301094998e3a3f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100301094998e3a3f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LCTX","BK4224","BK4139","LENZ"],"gpt_icon":0},{"id":"2470080406","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.16%报0.906美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470080406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470080406?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:02","pubTimestamp":1727449372,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时02分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速上涨5.16%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927230253ab668694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927230253ab668694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4224","BK4139","LINE","LENZ"],"gpt_icon":0},{"id":"2470944634","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470944634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470944634?lang=zh_cn&edition=full","pubTime":"2024-09-25 03:20","pubTimestamp":1727205639,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日03时20分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅下跌5.24%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925032039a1dc4028&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925032039a1dc4028&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","BK4224","LINE","LENZ"],"gpt_icon":0},{"id":"2460001519","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速上涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460001519","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460001519?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:31","pubTimestamp":1724160665,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时31分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速上涨5.60%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Fibrobiologics, Inc.涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Alzamend Neuro, Inc.较为活跃，换手率分别为1615.70%、313.01%、158.52%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、泰坦制药、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为50.54%、15.14%、8.52%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213106971994b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213106971994b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4224","BK4139","LINE","LENZ"],"gpt_icon":0},{"id":"2460393807","title":"Lineage Cell Therapeutics, Inc.2024财年第二财季实现净利润-5.76百万美元，同比减少10.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460393807","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460393807?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:03","pubTimestamp":1723910639,"startTime":"0","endTime":"0","summary":"8月18日，Lineage Cell Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-5.76百万美元，同比减少10.13%；其中营业收入为1.41百万美元，同比减少56.35%，每股基本收益为-0.03美元。从资产负债表来看，Lineage Cell Therapeutics, Inc.总负债35.93百万美元，其中短期债务1.12百万美元，资产负债比为0.03，流动比率为2.65。机构评级：截至2024年8月18日，当前有5家机构对Lineage Cell Therapeutics, Inc.目标价做出预测，其中目标均价为5.20美元，其中最低目标价为4.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006139f340713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006139f340713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LENZ","LCTX"],"gpt_icon":0},{"id":"2459420281","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.82%报0.849美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459420281","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459420281?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:30","pubTimestamp":1723728631,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时30分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速拉升5.82%。截至发稿，该股报0.849美元/股，成交量1.2352万股，换手率0.01%，振幅0.00%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213031ab5dd80f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213031ab5dd80f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LENZ","LINE","BK4139","BK4224"],"gpt_icon":0},{"id":"2459101568","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅下挫5.09%报0.787美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459101568","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459101568?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:40","pubTimestamp":1723650049,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日23时40分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速跳水5.09%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Zura Bio Limited C/Wts 、Unicycive Therapeutics, Inc.、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为89.12%、75.76%、67.06%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814234049ab5db11a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814234049ab5db11a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LENZ","BK4224","LCTX","BK4139"],"gpt_icon":0},{"id":"2459935222","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459935222","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459935222?lang=zh_cn&edition=full","pubTime":"2024-08-13 00:30","pubTimestamp":1723480208,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日00时30分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速下挫5.65%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.34%。其相关个股中，Revance Therapeutics, Inc.、Entero Therapeutics Inc.、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，60 Degrees Pharmaceuticals, Inc.、Entero Therapeutics Inc.、Oragenics Inc.较为活跃，换手率分别为645.96%、607.56%、82.05%，振幅较大的相关个股有Entero Therapeutics Inc.、60 Degrees Pharmaceuticals, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为117.04%、91.10%、50.70%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813003008af9718cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813003008af9718cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","BK4139","LENZ","LCTX"],"gpt_icon":0},{"id":"2458998155","title":"Lineage Cell Therapeutics, Inc.盘中异动 急速上涨5.61%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458998155","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458998155?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:34","pubTimestamp":1723210459,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时34分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅上涨5.61%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc涨幅较大，Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃，换手率分别为35.47%、6.11%、5.65%，振幅较大的相关个股有An2 Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为18.69%、15.53%、11.17%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092134199f1dc2dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092134199f1dc2dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","LCTX","BK4139"],"gpt_icon":0},{"id":"2457316967","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅拉升5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457316967","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457316967?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:33","pubTimestamp":1723123998,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时33分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速上涨5.90%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Anew Medical, Inc.涨幅较大，Anew Medical, Inc.、Conduit Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为184.10%、181.14%、40.52%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Generation Bio Co.，振幅分别为31.27%、17.43%、14.41%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213318958900d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213318958900d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4139","LCTX","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lineagecell.com","stockEarnings":[{"period":"1week","weight":-0.322},{"period":"1month","weight":-0.3226},{"period":"3month","weight":-0.3672},{"period":"6month","weight":-0.4286},{"period":"1year","weight":-0.4},{"period":"ytd","weight":-0.4495}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage Cell Therapeutics, Inc.于1990年在加利福尼亚州成立。该公司是一家临床阶段的生物技术公司，开发新的细胞疗法，以解决未得到满足的医疗需求。该公司的项目基于专有的基于细胞的技术平台以及相关的开发和制造能力。在这个平台上，该公司设计、开发、制造和测试具有与人体自然细胞相似或相同的解剖学和生理功能的专门人体细胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.069381},{"month":2,"riseRate":0.294118,"avgChangeRate":-0.036986},{"month":3,"riseRate":0.705882,"avgChangeRate":0.072614},{"month":4,"riseRate":0.294118,"avgChangeRate":-0.076478},{"month":5,"riseRate":0.411765,"avgChangeRate":-0.045447},{"month":6,"riseRate":0.411765,"avgChangeRate":0.010105},{"month":7,"riseRate":0.294118,"avgChangeRate":-0.032338},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.043311},{"month":9,"riseRate":0.5,"avgChangeRate":-0.001843},{"month":10,"riseRate":0.411765,"avgChangeRate":0.657436},{"month":11,"riseRate":0.411765,"avgChangeRate":0.004002},{"month":12,"riseRate":0.625,"avgChangeRate":0.029638}],"exchange":"AMEX","name":"Lineage Cell Therapeutics Inc","nameEN":"Lineage Cell Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lineage Cell Therapeutics Inc(LCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lineage Cell Therapeutics Inc,LCTX,Lineage Cell Therapeutics Inc股票,Lineage Cell Therapeutics Inc股票老虎,Lineage Cell Therapeutics Inc股票老虎国际,Lineage Cell Therapeutics Inc行情,Lineage Cell Therapeutics Inc股票行情,Lineage Cell Therapeutics Inc股价,Lineage Cell Therapeutics Inc股市,Lineage Cell Therapeutics Inc股票价格,Lineage Cell Therapeutics Inc股票交易,Lineage Cell Therapeutics Inc股票购买,Lineage Cell Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lineage Cell Therapeutics Inc(LCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}